Search Results - "Winneker, R C"

Refine Results
  1. 1

    Progress and Prospects in Treating Postmenopausal Vaginal Atrophy by Winneker, R C, Harris, H A

    Published in Clinical pharmacology and therapeutics (01-01-2011)
    “…Anatomically described as a “potential space,” the vagina is a highly estrogen‐responsive organ, and its biology changes dramatically at menopause. After…”
    Get full text
    Journal Article
  2. 2

    Selective and opposing actions of progesterone receptor isoforms in human endometrial stromal cells by Yudt, M.R., Berrodin, T.J., Jelinsky, S.A., Hanna, L.A., Brown, E.L., Chippari, S., Bhat, R.A., Winneker, R.C., Zhang, Z.

    Published in Molecular and cellular endocrinology (09-03-2006)
    “…Transcriptional regulation by progesterone is mediated primarily through the two progesterone receptor (PR) isoforms, PR-A and PR-B. Primary human endometrial…”
    Get full text
    Journal Article
  3. 3

    The effect of estrogens and antiestrogens in a rat model for hot flush by Merchenthaler, Istvan, Funkhouser, Judith M., Carver, Jeffrey M., Lundeen, Scott G., Ghosh, Krishnendu, Winneker, Richard C.

    Published in Maturitas (16-11-1998)
    “…The present studies evaluated the effect of estrogens and the selective estrogen receptor modulator (SERM) tamoxifen and raloxifene in a rat model for hot…”
    Get full text
    Journal Article
  4. 4

    In vitro characterization of trimegestone: a new potent and selective progestin by Zhang, Zhiming, Lundeen, Scott G, Zhu, Yuan, Carver, Jeffrey M, Winneker, Richard C

    Published in Steroids (01-10-2000)
    “…Trimegestone (TMG) is a novel 19-norpregnane progestin under development for hormone replacement therapy and oral contraception. The objective of the current…”
    Get full text
    Journal Article Conference Proceeding
  5. 5

    Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat by Shirk, Rebecca A., Zhang, Zhiming, Winneker, Richard C.

    “…Oral contraceptives (OC) and postmenopausal hormone therapy (HT) modulate plasma levels of proteins that regulate blood coagulation. It remains unclear whether…”
    Get full text
    Journal Article
  6. 6

    Serotonin 5-HT1 receptors potentiate histamine and thrombin stimulated prostaglandin synthesis in endothelial cells by Kilbourne, E J, Winneker, R C

    Published in Thrombosis and haemostasis (2001)
    “…The ability of serotonin 5-HT1 receptors to increase vascular tone was previously found to be activated by vasoconstrictiors such as histamine. In this study,…”
    Get more information
    Journal Article
  7. 7

    The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs by Juniewicz, P E, McCarthy, M, Lemp, B M, Barbolt, T A, Shaw, C, Hollenbaugh, D M, Winneker, R C, Reel, J R, Batzold, F H

    Published in Endocrinology (Philadelphia) (01-05-1990)
    “…The effect of the steroidal androgen receptor antagonist Win 49,596 on the prostate and testis was studied in beagle dogs and was compared to the effects of…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist by Snyder, B W, Winneker, R C, Batzold, F H

    Published in Journal of steroid biochemistry (01-12-1989)
    “…Win 49596 is a new orally active, steroidal androgen receptor antagonist. Win 49596 inhibited ventral prostate, seminal vesicle and levator ani weight gain in…”
    Get more information
    Journal Article
  10. 10

    Studies on the mechanism of action of danazol and gestrinone (R2323) in the rat: evidence for a masked estrogen component by Snyder, B W, Beecham, G D, Winneker, R C

    Published in Fertility and sterility (01-04-1989)
    “…The effects of androgen and estrogen receptor antagonists on the action of danazol and gestrinone (R2323) were investigated. The tropic effect of danazol and…”
    Get more information
    Journal Article
  11. 11

    Effect of epostane, ZK 98299, and ZK 98734 on the interruption of pregnancy in the rat by SNYDER, B. W, REEL, J. R, WINNEKER, R. C, BATZOLD, F. H, POTTS, G. O

    Published in Biology of reproduction (01-03-1989)
    “…The objective of these studies was to determine whether treatment of 10-day pregnant rats with a combination of epostane (a progesterone biosynthesis…”
    Get full text
    Journal Article
  12. 12

    Characterization of the Ovariectomized Rat Model for the Evaluation of Estrogen Effects on Plasma Cholesterol Levels by Lundeen, Scott G, Carver, Jeffrey M, McKean, Mar-Lee, Winneker, Richard C

    Published in Endocrinology (Philadelphia) (01-04-1997)
    “…Estrogens protect against cardiovascular disease in women through effects on the vascular wall and liver. Here we further characterize the rat as a model for…”
    Get full text
    Journal Article
  13. 13

    Danazol suppression of luteinizing hormone in the rat: evidence for mediation by both androgen and estrogen receptors by Snyder, B W, Beecham, G D, Winneker, R C

    “…Previous studies had indicated that the effects of danazol on rat peripheral tissues were mediated through both androgen and estrogen receptors. The purpose of…”
    Get more information
    Journal Article
  14. 14

    Rat uterine complement C3 expression as a model for progesterone receptor modulators: characterization of the new progestin trimegestone by Lundeen, Scott G, Zhang, Zhiming, Zhu, Yuan, Carver, Jeffrey M, Winneker, Richard C

    “…Progestins have a wide variety of activities in female reproduction. There are also pharmacological applications for progestins, including hormone replacement…”
    Get full text
    Journal Article
  15. 15

    Studies on the mechanism of action of Win 49596: a steroidal androgen receptor antagonist by Winneker, R C, Wagner, M M, Batzold, F H

    Published in Journal of steroid biochemistry (01-12-1989)
    “…Win 49596 is an orally active antiandrogen in the rat. This report describes a series of in vitro and in vivo studies which were performed to characterize the…”
    Get more information
    Journal Article
  16. 16

    Antiandrogenic steroidal sulfonyl heterocycles. Utility of electrostatic complementarity in defining bioisosteric sulfonyl heterocycles by Mallamo, John P, Pilling, Garry M, Wetzel, Joseph R, Kowalczyk, Paul J, Bell, Malcolm R, Kullnig, Rudolph K, Batzold, Frederick H, Juniewicz, Paul E, Winneker, Richard C, Luss, Henry R

    Published in Journal of medicinal chemistry (01-05-1992)
    “…Complementarity of electrostatic potential surface maps was utilized in defining bioisosteric steroidal androgen receptor antagonists. Semiempirical and ab…”
    Get full text
    Journal Article
  17. 17

    Antiandrogenic steroidal sulfonylpyrazoles by Christiansen, Robert G, Bell, Malcolm R, D'Ambra, Thomas E, Mallamo, John P, Herrmann, John L, Ackerman, James H, Opalka, Chester J, Kullnig, Rudolph K, Winneker, Richard C

    Published in Journal of medicinal chemistry (01-08-1990)
    “…The steroidal sulfonylpyrazole 1 bound to the rat ventral prostate androgen receptor in vitro; it inhibited testosterone propionate induced increases in…”
    Get full text
    Journal Article
  18. 18
  19. 19

    The preclinical biology of a new potent and selective progestin: trimegestone by Winneker, Richard C, Bitran, Daniel, Zhang, Zhiming

    Published in Steroids (01-11-2003)
    “…Trimegestone (TMG) is a 19-norpregnane progestin being developed, in combination with an estrogen, for the treatment of postmenopausal symptoms. TMG binds to…”
    Get full text
    Journal Article Conference Proceeding
  20. 20

    The angiogenic factor Cyr61 is induced by the progestin R5020 and is necessary for mammary adenocarcinoma cell growth by Sampath, Deepak, Winneker, Richard C, Zhang, Zhiming

    Published in Endocrine (01-07-2002)
    “…Cyr61 is a secreted pro-angiogenic factor that belongs to an emerging family of growth regulators classified as CCN (CTGF/Cyr61/NOV). Work in our laboratory…”
    Get full text
    Journal Article